This is the authors' abstract. We don't add key points for this paper.
Idiopathic inflammatory myopathies (IIMs) or idiopathic-acquired myopathies represent a heterogeneous group of rare autoimmune diseases [ 1 , 2 , 3 ]. This group is made up of a set of acquired muscular disorders resulting from the dysregulation of the immune system. They can sometimes be associated with extramuscular autoimmune manifestations or cancer [ 1 , 4 ]. The understanding of the pathophysiology of IIMs, their serological and histological specificity and above all the recent advent of myositis-specific autoantibodies (MSAs) have contributed to refining their classification. This classification, which is not unanimously accepted, includes dermatomyositis, inclusion myositis, autoimmune necrotising myositis and overlapping myositis and antisynthetase syndrome (ASS) and myositis associated with connective tissue disease [ 2 , 4 , 5 ]. ASS is characterised by muscle weakness, diffuse interstitial lung disease (ILD), polyarthritis, skin damage such as “mechanic’s hands” and, to a lesser extent, Raynaud’s phenomenon. Biologically, it is associated with autoantibodies of the antisynthetase family, the most frequent being the anti-Jo1 [ 6 ]. Studies on ASS are not numerous in sub-Saharan Africa. In Senegal, only two case-report studies have been published concerning this condition [ 7 , 8 ]. In this context, we conducted a multicentric and descriptive study about epidemiological, diagnostic and immunological aspects of ASS.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kane et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: